Shorla Oncology develops innovative oncology drugs for women's and pediatric cancers, focusing on life-saving treatments.
Shorla Oncology has raised $29.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
Shorla Oncology's investors include Irish Venture Capital Association.
Shorla Oncology is headquartered in Clonmel, Ireland.
Shorla Oncology develops innovative oncology drugs for women's and pediatric cancers, focusing on life-saving treatments.
Shorla Oncology is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shorla Oncology — Funding & Investors." VCBacked, February 8, 2026, https://www.vcbacked.co/company/shorla-oncology. Accessed October 8, 2026.
VCBacked. (2026). Shorla Oncology — Funding & Investors. Retrieved October 8, 2026, from https://www.vcbacked.co/company/shorla-oncology
{{cite web |title=Shorla Oncology — Funding & Investors |url=https://www.vcbacked.co/company/shorla-oncology |website=VCBacked |access-date=October 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated